Marie O'Donnell Edinburgh Urological Cancer Group University of Edinburgh Biography Publications Institution JoVE Articles Marie O'Donnell has not added a biography. If you are Marie O'Donnell and would like to personalize this page please email our Author Liaison for assistance. Publications 表观遗传检测检测中活检病理组织学检查消极的隐匿性前列腺癌的临床实用程序: MATLOC 研究的结果。 The Journal of Urology. Sep, 2012 | Pubmed ID: 22999998 核心蛋白聚糖、 Semaphorin6D、 SPARC、 Sprouty1 和发展核心蛋白聚糖在前列腺癌中的前列腺和减少各级笊紫的基质表达式。 PloS One. 2012 | Pubmed ID: 22880013 海底总动员抑制的抑制 RIP1 NFκB 独立方式编程的坏死。 PloS One. 2012 | Pubmed ID: 22848449 NFκB 和泛: 伙伴解除 RIPK1 介导细胞死亡。 Immunologic Research. Dec, 2012 | Pubmed ID: 22477525 8 半胱氨酸蛋白酶抑制程控的坏死的加工油缸。 Nature Cell Biology. Dec, 2011 | Pubmed ID: 22037414 RIP1 回到生活作为一个细胞死亡监管 TNFR1 信号。 The FEBS Journal. Apr, 2011 | Pubmed ID: 21232018 编年史的死亡预言: 肿瘤坏死因子信号转导的双连续的单元格死亡检查站。 Cell Cycle (Georgetown, Tex.). Mar, 2010 | Pubmed ID: 20237426 肿瘤抑癌油缸是负稳压的钻机我介导的抗病毒反应。 EMBO Reports. Sep, 2008 | Pubmed ID: 18636086 RIP1 泛规管在肿瘤坏死因子信号转导独立的 NF-活化细胞死亡开关。 Current Biology : CB. Mar, 2007 | Pubmed ID: 17306544 肾疤痕引起的膀胱输尿管返流和尿路感染: 猪的研究。 Pediatric Nephrology (Berlin, Germany). Jul, 2002 | Pubmed ID: 12172758 S100A4 蛋白的表达与转移相关联,并减少在膀胱癌中的生存。 The Journal of Pathology. Mar, 2002 | Pubmed ID: 11857492 使用反时相蛋白的阵列(RPPA)探索在个人的肾细胞癌蛋白表达的变化 Fiach C. O'Mahony1, Jyoti Nanda1, Alexander Laird1, Peter Mullen2, Helen Caldwell3, Ian M. Overton4, Lel Eory4, Marie O'Donnell1,5, Dana Faratian6, Thomas Powles7, David J. Harrison1,2, Grant D. Stewart1 1Edinburgh Urological Cancer Group, University of Edinburgh, 2School of Medicine, University of St Andrews, 3Division of Pathology, University of Edinburgh, 4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, 5Department of Pathology, Western General Hospital, 6Breakthrough Breast Cancer Research Unit, University of Edinburgh, 7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London JoVE 50221 Medicine
使用反时相蛋白的阵列(RPPA)探索在个人的肾细胞癌蛋白表达的变化 Fiach C. O'Mahony1, Jyoti Nanda1, Alexander Laird1, Peter Mullen2, Helen Caldwell3, Ian M. Overton4, Lel Eory4, Marie O'Donnell1,5, Dana Faratian6, Thomas Powles7, David J. Harrison1,2, Grant D. Stewart1 1Edinburgh Urological Cancer Group, University of Edinburgh, 2School of Medicine, University of St Andrews, 3Division of Pathology, University of Edinburgh, 4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, 5Department of Pathology, Western General Hospital, 6Breakthrough Breast Cancer Research Unit, University of Edinburgh, 7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London JoVE 50221 Medicine